This American Depositary Receipt (ADR) represent shares in Adlai Nortye, a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types.
This American Depositary Receipt (ADR) represent shares in Adlai Nortye, a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types.